<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Cefixime - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Cefixime</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../../index.html">Home</a>
        <a class="btn small" href="../../index.html#/sickbay-meds">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Antibiotics / Antivirals</div>
      <h1>Cefixime</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Cefixime 400mg Tablets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Uncomplicated gonorrhea (urethral, cervical, rectal)</strong>
            <ul>
              <li>800 mg PO as a single dose (current Canadian guideline recommendation due to resistance concerns)</li>
              <li>Note: Older guidelines used 400 mg; verify current local protocol</li>
            </ul>
          </li>
          <li><strong>Acute bacterial exacerbation of chronic bronchitis</strong>
            <ul>
              <li>400 mg PO once daily for 10 days</li>
            </ul>
          </li>
          <li><strong>Pharyngitis/tonsillitis (streptococcal)</strong>
            <ul>
              <li>400 mg PO once daily for 10 days</li>
            </ul>
          </li>
          <li><strong>Uncomplicated urinary tract infection</strong>
            <ul>
              <li>400 mg PO once daily for 7–10 days (or per local protocol)</li>
            </ul>
          </li>
          <li><strong>Acute otitis media (when oral cephalosporin appropriate)</strong>
            <ul>
              <li>400 mg PO once daily for 5–10 days</li>
            </ul>
          </li>
          <li><strong>Renal impairment dosing</strong>
            <ul>
              <li>Dose reduction required for CrCl &lt;60 mL/min: follow product monograph or clinical reference</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Uncomplicated gonorrhea (per current resistance guidelines)</li>
          <li>Susceptible respiratory tract infections (pharyngitis, bronchitis, otitis media)</li>
          <li>Uncomplicated urinary tract infections</li>
          <li>Third-generation cephalosporin with broader gram-negative coverage than first/second-generation agents</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Hypersensitivity to cefixime or other cephalosporins</li>
          <li>History of immediate/severe hypersensitivity to penicillins (risk of cross-reactivity; assess severity and type of reaction)</li>
          <li>Renal impairment: dose adjustment required</li>
          <li>C. difficile-associated diarrhea risk: reassess if significant diarrhea develops during/after therapy</li>
          <li>Not effective against MRSA, Pseudomonas, or atypical respiratory pathogens</li>
          <li>Gonorrhea: increasing resistance; use 800 mg dose and consider dual therapy per guidelines (e.g., with azithromycin)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>GI upset (diarrhea, nausea, abdominal pain) – common</li>
          <li>Hypersensitivity reactions (rash, urticaria; rarely anaphylaxis)</li>
          <li>C. difficile-associated diarrhea</li>
          <li>Headache, dizziness</li>
          <li>Elevated liver enzymes (transient)</li>
          <li>Hematologic effects (eosinophilia, thrombocytopenia – uncommon)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>May be taken with or without food</li>
          <li>Taking with food may reduce GI upset</li>
          <li>Counsel: finish the prescribed course unless told otherwise; do not share leftover antibiotics</li>
          <li>For gonorrhea treatment: ensure partner notification and testing per public health guidelines</li>
          <li>Tablets should be swallowed whole with water</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Clinical response within 48–72 hours (symptoms, fever, function)</li>
          <li>Allergy/rash; stop and seek help if signs of anaphylaxis</li>
          <li>Diarrhea severity (consider C. difficile if severe/persistent)</li>
          <li>For gonorrhea treatment: test of cure recommended (especially pharyngeal infections); follow local STI guidelines</li>
          <li>Renal function monitoring if prolonged therapy or high-risk patient</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Useful oral third-generation cephalosporin for selected infections when broader gram-negative coverage needed</li>
          <li>For gonorrhea: verify current dosing recommendations (800 mg preferred in Canada); consider dual therapy and partner management per guidelines</li>
          <li>Confirm indication and avoid antibiotics for likely viral/self-limited illness when possible (stewardship)</li>
          <li>If diagnostics are limited, reassess early non-response and consider alternate diagnosis or need for escalation/evac</li>
          <li>Document start date, dose, planned duration, and allergy status clearly</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (Cefixime tablets): <a href="https://pdf.hres.ca/dpd_pm/00066934.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00066934.PDF</a></li>
          <li>Canadian Guidelines on Sexually Transmitted Infections – Gonococcal Infections: <a href="https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/gonococcal-infections.html" target="_blank" rel="noopener">https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/gonococcal-infections.html</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
